Liver fibrosis
Liver fibrosis is a pathological condition characterized by the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. It is the result of a wound-healing response to liver injury, which can be caused by a variety of factors such as hepatitis, alcohol abuse, and non-alcoholic fatty liver disease (NAFLD).
Etiology[edit | edit source]
Liver fibrosis can be caused by several factors. Chronic viral hepatitis (Hepatitis B and C) is one of the most common causes worldwide. Other causes include alcoholic liver disease, non-alcoholic steatohepatitis (NASH), autoimmune hepatitis, biliary disease, and metabolic diseases such as hemochromatosis and Wilson's disease.
Pathogenesis[edit | edit source]
The pathogenesis of liver fibrosis involves the activation of hepatic stellate cells (HSCs) in response to liver injury. Activated HSCs transform into myofibroblast-like cells, which produce extracellular matrix proteins, including collagen. The excessive accumulation of these proteins leads to the formation of a fibrous scar, disrupting the normal architecture of the liver.
Clinical Manifestations[edit | edit source]
The clinical manifestations of liver fibrosis can vary depending on the stage of the disease. Early stages may be asymptomatic, while advanced stages can lead to cirrhosis, characterized by symptoms such as jaundice, ascites, hepatic encephalopathy, and variceal bleeding.
Diagnosis[edit | edit source]
Diagnosis of liver fibrosis is typically based on a combination of clinical history, physical examination, laboratory tests, and imaging studies. Liver biopsy is considered the gold standard for diagnosing and staging liver fibrosis, but non-invasive methods such as elastography and serum biomarkers are increasingly used due to their lower risk of complications.
Treatment[edit | edit source]
The treatment of liver fibrosis primarily involves managing the underlying cause. This may include antiviral therapy for viral hepatitis, lifestyle modifications for alcoholic liver disease and NAFLD, and immunosuppressive therapy for autoimmune hepatitis. In advanced cases, liver transplantation may be considered.
Prognosis[edit | edit source]
The prognosis of liver fibrosis depends on the underlying cause and the stage of the disease at the time of diagnosis. Early detection and treatment can halt the progression of fibrosis and potentially reverse some of the damage.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD